CA3209594C - Composition pharmaceutique comprenant l'hormone de croissance 6, ghrp-6 - Google Patents

Composition pharmaceutique comprenant l'hormone de croissance 6, ghrp-6

Info

Publication number
CA3209594C
CA3209594C CA3209594A CA3209594A CA3209594C CA 3209594 C CA3209594 C CA 3209594C CA 3209594 A CA3209594 A CA 3209594A CA 3209594 A CA3209594 A CA 3209594A CA 3209594 C CA3209594 C CA 3209594C
Authority
CA
Canada
Prior art keywords
ghrp
formulation
peptide
tartrate
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3209594A
Other languages
English (en)
Other versions
CA3209594A1 (fr
Inventor
Hector Jesus Santana Milian
Francisco HERNANDEZ BERNAL
Sonia Gonzalez Blanco
Yasser ZARATE RIVERA
Dania Mercedes Bacardi Fernandez
Diana Garcia Del Barco Herrera
Yaima Gonzalez Gonzalez
Fidel Raul Castro Odio
Jorge Amador Berlanga Acosta
Gerardo Enrique Guillen Nieto
Juan VALIENTE MUSTELIER
Original Assignee
Centro de Ingenieria Genetica y Biotecnologia CIGB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CU2021000010A external-priority patent/CU24723B1/es
Application filed by Centro de Ingenieria Genetica y Biotecnologia CIGB filed Critical Centro de Ingenieria Genetica y Biotecnologia CIGB
Publication of CA3209594A1 publication Critical patent/CA3209594A1/fr
Application granted granted Critical
Publication of CA3209594C publication Critical patent/CA3209594C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne une composition pharmaceutique comprenant l'hormone de croissance 6, (GHRP-6), le tampon tartrate à un pH 5,0-6,0 et du tréhalose comme agent stabilisant; ainsi que l'utilisation de cette composition pour la fabrication d'un médicament. L'invention concerne également un kit d'éléments qui comprend ladite composition pharmaceutique et une méthode de traitement d'un individu qui en a besoin, dans laquelle méthode on administre une quantité thérapeutiquement efficace de la composition pharmaceutique qui comprend le peptide libérant l'hormone de croissance 6, (GHRP-6), le tampon tartrate à un pH de 5,0-0,6 et du tréhalose.
CA3209594A 2021-01-29 2022-01-27 Composition pharmaceutique comprenant l'hormone de croissance 6, ghrp-6 Active CA3209594C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CU2021000010A CU24723B1 (es) 2021-01-29 2021-01-29 Composición farmacéutica que comprende el ghrp-6
CUCU2021-0010 2021-01-29
PCT/CU2022/050001 WO2022161554A1 (fr) 2021-01-29 2022-01-27 Composition pharmaceutique comprenant l'hormone de croissance 6, ghrp-6

Publications (2)

Publication Number Publication Date
CA3209594A1 CA3209594A1 (fr) 2022-08-04
CA3209594C true CA3209594C (fr) 2026-05-05

Family

ID=

Similar Documents

Publication Publication Date Title
EP1246639B1 (fr) Formulations de glp-2
US11959486B2 (en) Stable liquid formulation of AMG 416 (etelcalcetide)
US10532069B2 (en) Compositions and methods for treating joints
CN118766886A (zh) 达托霉素制剂
HK1214149A1 (zh) 芳基硫酸酯酶 a cns 递送的方法和组合物
ES2679520T3 (es) Formulaciones de moléculas del factor de liberación de hormonas del crecimiento (GRF) con estabilidad mejorada
JPH05331071A (ja) カルシトニン遺伝子関連ペプチド類の凍結乾燥組成物および安定化法
CN102670522A (zh) 含有重组人血清白蛋白-人粒细胞集落刺激因子融合蛋白的药物制剂及其制备
US12564619B2 (en) Stable formulations of recombinant proteins
CA3011609A1 (fr) Formulation pharmaceutique lyophilisee et son utilisation
EP4285891B1 (fr) Composition pharmaceutique comprenant l'hormone de croissance 6, ghrp-6
ES2363738T3 (es) Formulación de aviptadil.
US20190083578A1 (en) Use of low dose glucagon
JP4880845B2 (ja) Ｇｒｆ含有凍結乾燥薬剤組成物
HK1122214A (en) Formulation for aviptadil
HK1246697A1 (en) Stable liquid formulation of amg 416 hcl (etelcalcetide)
HK1246697B (en) Stable liquid formulation of amg 416 hcl (etelcalcetide)
HK1222557B (en) Stable liquid formulation of amg 416 (velcalcetide)
HK1050142A1 (en) Glp-2 formulations
HK1050142B (en) Glp-2 formulations